FB
FibroBiologics, Inc. Common Stock
FBLG · NASDAQ
$1.71 -5.00% (-$0.09)
1M +74.49%
Market Cap $3.58M
P/E Ratio -
Div. Yield -
ROE 536.78%
Bulios Fair Price
$1.76
2.9% upside
Current Price
$1.71
Undervalued Fair Value Overvalued
According to Bulios Fair Price, FBLG is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.77x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 274.34%
ROE 536.78%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.32x
Current ratio 2.64x
Int. coverage -83.01x
Stability
22 /100
Unstable Beta 1.22x
EPS volatility 163.95%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about FBLG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter O'Heeron
Employees
15
Headquarters
Houston
Upcoming events
30 OCT
Earnings
Upcoming earnings report